Elanco Animal Health Inc (NYSE:ELAN)
$ 17 -0.2 (-1.16%) Market Cap: 8.40 Bil Enterprise Value: 13.92 Bil PE Ratio: 0 PB Ratio: 1.40 GF Score: 70/100

Elanco Animal Health Inc to Acquire Animal Health Business of Bayer AG Call Transcript

Aug 20, 2019 / 12:00PM GMT
Release Date Price: $27.26 (-8.55%)
Operator

Good morning. My name is Jessa, and I will be your conference operator today. At this time, I would like to welcome everyone to the Elanco Investor Call. (Operator Instructions)

Thank you. Mr. Jim Greffet, you may begin your conference.

Jim Greffet
Elanco Animal Health Incorporated - Head of IR

Thanks, Jessa. Good morning. Thank you for joining us as we announced an important strategic investment for Elanco. I'm Jim Greffet, the Head of Investor Relations. Joining me are Jeff Simmons, President and Chief Executive Officer; Todd Young, our Chief Financial Officer; Aaron Schacht, Executive Vice President, R&D and Business Development; and Katy Grissom from Investor Relations.

During this conference call, we anticipate making projections and forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. For example, our results may be affected by competitive developments, the timing and success of new product launches, regulatory and legal matters, government

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot